Word

LISATA

Status

Pending

Status Code

730

Status Date

Friday, November 10, 2023

Serial Number

97377210

Mark Type

4000

Filing Date

Friday, April 22, 2022

Published for Opposition

Tuesday, April 18, 2023

Trademark Owner History

LISATA THERAPEUTICS, INC. - 1st New Owner After Publication
Caladrius Biosciences, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for use in cancer, tumors, diabetic kidney disease, coronary microvascular dysfunction, Buerger's Disease, and Critical Limb Ischemia; Pharmaceutical preparations for use in treating and managing diseases, disorders, and conditions involving oncology, cardiology, vascular system, and ischemia; Therapeutic pharmaceutical preparations for enhancing the targeting, delivery, and effectiveness of cancer treatments; Therapeutic agents for promoting ischematic repair, regenerating damaged tissue, stimulating the repair or growth of microvasculature, penetrating tissue surrounding tumors, and altering immunosuppressive tumor microenvironments

42 Research and development in the fields of pharmaceuticals, biotechnology, cell therapies, drug delivery technologies, oncology, cardiology, vascular system, and ischemia; Providing medical scientific information in the fields of pharmaceuticals, biotechnology, cell therapies, drug delivery technologies, oncology, cardiology, vascular system, and ischemia; Drug discovery services

The English translation of "LISATA" in the mark is "AUGMENT".

Trademark Events

Nov 22, 2023

Automatic Update Of Assignment Of Ownership

Nov 14, 2023

Notice Of Approval Of Extension Request E-Mailed

Nov 10, 2023

Sou Extension 1 Granted

Nov 10, 2023

Sou Extension 1 Filed

Nov 10, 2023

Sou Teas Extension Received

Jun 13, 2023

Noa E-Mailed - Sou Required From Applicant

Apr 18, 2023

Official Gazette Publication Confirmation E-Mailed

Apr 18, 2023

Published For Opposition

Mar 29, 2023

Notification Of Notice Of Publication E-Mailed

Mar 13, 2023

Approved For Pub - Principal Register

Mar 3, 2023

Teas/Email Correspondence Entered

Mar 3, 2023

Correspondence Received In Law Office

Mar 3, 2023

Teas Response To Office Action Received

Feb 16, 2023

Notification Of Non-Final Action E-Mailed

Feb 16, 2023

Non-Final Action E-Mailed

Feb 16, 2023

Non-Final Action Written

Feb 9, 2023

Assigned To Examiner

Apr 28, 2022

New Application Office Supplied Data Entered

Apr 26, 2022

New Application Entered